Browsing by Author André Poisl Fay

Skip to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing rec. 1 to 20 of 65    next ►  
Issue DateTitleAuthor(s)
2021A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)MALUF, FERNANDO C.; SCHUTZ, FABIO A.; CRONEMBERGER, EDUARDO H., et al
2022A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)MONTEIRO, FERNANDO SABINO M.; SOARES, ANDREY; SOUZA, VINICIUS CARRERA, et al
2020Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)Andrey Soares; MONTEIRO, FERNANDO SABINO MARQUES; MALUF, FERNANDO C., et al
2018Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.TONETO, MARCELO GARCIA; DEPAULA, PEDRO LUCAS; DEBON, LETÍCIA, et al
2018Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.TONETO, MARCELO GARCIA; DEPAULA, PEDRO LUCAS; DEBON, LETÍCIA, et al
2015Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinomaJoaquim Bellmunt; MULLANE, S. A.; WERNER, L., et al
2016Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapyBELLMUNT, JOAQUIM; ZHOU, CHENSHENG WILLA; MULLANE, STEPHANIE A, et al
2019Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?André Poisl Fay; ANTONARAKIS, EMMANUEL S.
2016Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of EfficacyTEMPLETON, ARNOUD J.; KNOX, JENNIFER J.; LIN, XUN, et al
2015Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled TrialCHOUEIRI, T. K.; FIGUEROA, D. J.; André Poisl Fay, et al
2015Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspectiveStephen Doral Stefani; Vanessa Teich; André Poisl Fay, et al
2015Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspectiveStephen Doral Stefani; Vanessa Teich; André Poisl Fay, et al
2015Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma.CALLEA, MARCELLA; ALBIGES, LAURENCE; Mampta Gupta, et al
2017Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsMOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al
2017Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trialsMOREIRA, RAPHAEL B.; Marcio Debiasi; FRANCINI, EDOARDO, et al
2020Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trialVAN DER HEIJDEN, MICHIEL S; GALSKY, MATTHEW D; PETRYLAK, DANIEL P, et al
2015Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinomaALBIGES, LAURENCE; André Poisl Fay; XIE, WANLING, et al
2017ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysisURUN, YUKSEL; LEOW, JEFFREY J.; André Poisl Fay, et al
2020First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysisMONTEIRO, FERNANDO SABINO M.; SOARES, ANDREY; DEBIASI, MÁRCIO, et al
2015HER2 as a target in invasive urothelial carcinomaBELLMUNT, JOAQUIM; WERNER, LILLIAN; BAMIAS, ARISTOTLE, et al